Euroapi Company Header Euroapi Company Header

X

Find AZD5153 manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

AZD5153
Also known as: Azd-5153, Azd5153, 1869912-39-9, C7c7u6yeao, Chembl4078100, Azd 5153 [who-dd]
Molecular Formula
C25H33N7O3
Molecular Weight
479.6  g/mol
InChI Key
RSMYFSPOTCDHHJ-GOSISDBHSA-N
FDA UNII
C7C7U6YEAO

Bivalent BRD4 Inhibitor AZD5153 is an orally bioavailable bivalent inhibitor of bromodomain-containing protein 4 (BRD4), with potential antineoplastic activity. Upon oral administration, the BRD4 inhibitor AZD5153 selectively binds to the acetylated lysine recognition motifs in two bromodomains in the BRD4 protein, thereby preventing the binding of BRD4 to acetylated lysines on histones. This disrupts chromatin remodeling and dysregulates expression of target genes, which leads to the downregulation of the expression of certain growth-promoting genes, induces apoptosis and inhibits the proliferation of BRD4-overexpressing tumor cells. BRD4, a member of the human bromodomain and extra-terminal (BET) family of proteins, is a transcriptional regulator that is overexpressed in certain tumor cells and plays an important role in cellular proliferation.
1 2D Structure

AZD5153

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(3R)-4-[2-[4-[1-(3-methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl]phenoxy]ethyl]-1,3-dimethylpiperazin-2-one
2.1.2 InChI
InChI=1S/C25H33N7O3/c1-18-24(33)29(2)14-15-30(18)16-17-35-21-6-4-19(5-7-21)20-10-12-31(13-11-20)23-9-8-22-26-27-25(34-3)32(22)28-23/h4-9,18,20H,10-17H2,1-3H3/t18-/m1/s1
2.1.3 InChI Key
RSMYFSPOTCDHHJ-GOSISDBHSA-N
2.1.4 Canonical SMILES
CC1C(=O)N(CCN1CCOC2=CC=C(C=C2)C3CCN(CC3)C4=NN5C(=NN=C5OC)C=C4)C
2.1.5 Isomeric SMILES
C[C@@H]1C(=O)N(CCN1CCOC2=CC=C(C=C2)C3CCN(CC3)C4=NN5C(=NN=C5OC)C=C4)C
2.2 Other Identifiers
2.2.1 UNII
C7C7U6YEAO
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 4-(2-(4-(1-(3-methoxy-(1,2,4)triazolo(4,3-b)pyridazin-6-yl)-4-piperidyl)phenoxy)ethyl)-1,3-dimethylpiperazin-2-one

2. Azd 5153

3. Azd-5153

4. Azd5153

2.3.2 Depositor-Supplied Synonyms

1. Azd-5153

2. Azd5153

3. 1869912-39-9

4. C7c7u6yeao

5. Chembl4078100

6. Azd 5153 [who-dd]

7. Azd 5153

8. 1869912-39-9 (free Base)

9. (r)-4-(2-(4-(1-(3-methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl)phenoxy)ethyl)-1,3-dimethylpiperazin-2-one

10. 2-piperazinone, 4-(2-(4-(1-(3-methoxy-1,2,4-triazolo(4,3-b)pyridazin-6-yl)-4-piperidinyl)phenoxy)ethyl)-1,3-dimethyl-, (3r)-

11. Unii-c7c7u6yeao

12. Schembl17477306

13. Amy16812

14. Bcp20057

15. Ex-a1317

16. Azd5153, 6-hydroxy-2-naphthoate

17. Bdbm50260093

18. Mfcd30530420

19. Nsc797938

20. Akos030627661

21. Azd-5153, 6-hydroxy-2-naphthoate

22. Zinc575441177

23. Nsc-797938

24. Ac-31599

25. As-35242

26. J3.544.368a

27. Q27467599

28. (3r)-4-[2-[4-[1-(3-methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-4-piperidyl]phenoxy]ethyl]-1,3-dimethyl-piperazin-2-one

29. (3r)-4-[2-[4-[1-(3-methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl]phenoxy]ethyl]-1,3-dimethylpiperazin-2-one

30. Xnh

2.4 Create Date
2016-02-23
3 Chemical and Physical Properties
Molecular Weight 479.6 g/mol
Molecular Formula C25H33N7O3
XLogP32.4
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count8
Rotatable Bond Count7
Exact Mass479.26448794 g/mol
Monoisotopic Mass479.26448794 g/mol
Topological Polar Surface Area88.3 Ų
Heavy Atom Count35
Formal Charge0
Complexity699
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY